Angiogenin stimulates ribosomal RNA transcription by epigenetic activation of the ribosomal DNA promoter

Journal of Cellular Physiology

Volumn 229, Issue 4, 2014, Pages 521-529

  Sheng, Jinghao ^a,b   Yu, Wenhao ^a   Gao, Xiangwei ^b   Xu, Zhengping ^b   Hu, Guo Fu ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIN; DNA DIRECTED RNA POLYMERASE; HISTONE H3; HISTONE H4; MESSENGER RNA; REPETITIVE DNA; RIBOSOME DNA; RIBOSOME RNA;

ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DOWN REGULATION; EPIGENETICS; FEMALE; HISTONE ACETYLATION; HISTONE METHYLATION; HISTONE MODIFICATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; PRECURSOR; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; RNA TRANSCRIPTION; TRANSCRIPTION ELONGATION;

EID: 84890528071     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24477     Document Type: Article

References (51)

1. Bell SP, Learned RM, Jantzen HM, Tjian R. 1988. Functional cooperativity between transcription factors UBF1 and SL1 mediates human ribosomal RNA synthesis. Science 241:1192-1197.
2. Birch JL, Zomerdijk JC. 2008. Structure and function of ribosomal RNA gene chromatin. Biochem Soc Trans 36:619-624.
3. Drygin D, Rice WG, Grummt I. 2010. The RNA polymerase I transcription machinery: An emerging target for the treatment of cancer. Ann Rev Pharmacol Toxicol 50:131-156.
4. Fett JW, Strydom DJ, Lobb RR, Alderman EM, Bethune JL, Riordan JF, Vallee BL. 1985. Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry 24:5480-5486.
5. Gao X, Wei S, Lai K, Sheng J, Su J, Zhu J, Dong H, Hu H, Xu Z. 2010. Nucleolar follistatin promotes cancer cell survival under glucose-deprived condition through inhibiting cellular rRNA synthesis. J Biol Chem 285:36857-36864.
6. Grandori C, Gomez-Roman N, Felton-Edkins ZA, Ngouenet C, Galloway DA, Eisenman RN, White RJ. 2005. c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I. Nat Cell Biol 7:311-318.
7. Graveley BR, Fleming ES, Gilmartin GM. 1996. Restoration of both structure and function to a defective poly(A) site by in vitro selection. J Biol Chem 271:33654-33663.
8. Greenway MJ, Andersen PM, Russ C, Ennis S, Cashman S, Donaghy C, Patterson V, Swingler R, Kieran D, Prehn J, Morrison KE, Green A, Acharya KR, Brown RH Jr, Hardiman O. 2006. ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis. Nat Genet 38:411-413.
9. Grummt I. 2007. Different epigenetic layers engage in complex crosstalk to define the epigenetic state of mammalian rRNA genes. Hum Mol Genet 16: Spec No 1: R21-R27.
10. Grummt I, Langst G. 2013. Epigenetic control of RNA polymerase I transcription in mammalian cells. Biochim Biophys Acta 1829:393-404.
11. Hu GF. 1998. Neomycin inhibits angiogenin-induced angiogenesis. Proc Natl Acad Sci USA 95:9791-9795.
12. Hu GF, Chang SI, Riordan JF, Vallee BL. 1991. An angiogenin-binding protein from endothelial cells. Proc Natl Acad Sci USA 88:2227-2231.
13. Hu GF, Strydom DJ, Fett JW, Riordan JF, Vallee BL. 1993. Actin is a binding protein for angiogenin. Proc Natl Acad Sci USA 90:1217-1221.
14. Hu GF, Riordan JF, Vallee BL. 1997. A putative angiogenin receptor in angiogenin-responsive human endothelial cells. Proc Natl Acad Sci USA 94:2204-2209.
15. Hu G, Xu C, Riordan JF. 2000. Human angiogenin is rapidly translocated to the nucleus of human umbilical vein endothelial cells and binds to DNA. J Cell Biochem 76:452-462.
16. Ibaragi S, Yoshioka N, Kishikawa H, Hu JK, Sadow PM, Li M, Hu G-f. 2009a. Angiogenin-stimulated Ribosomal RNA Transcription Is Essential for Initiation and Survival of AKT-induced Prostate Intraepithelial Neoplasia. Mol Cancer Res 7:415-424.
17. Ibaragi S, Yoshioka N, Li S, Hu MG, Hirukawa S, Sadow PM, Hu G-f. 2009b. Neamine inhibits prostate cancer growth by suppressing angiogenin-mediated ribosomal RNA transcription. Clin Cancer Res 15:1981-1988.
18. Kieran D, Sebastia J, Greenway MJ, King MA, Connaughton D, Concannon CG, Fenner B, Hardiman O, Prehn JH. 2008. Control of motoneuron survival by angiogenin. J Neurosci 28:14056-14061.
19. Kishimoto K, Liu S, Tsuji T, Olson KA, Hu GF. 2005. Endogenous angiogenin in endothelial cells is a general requirement for cell proliferation and angiogenesis. Oncogene 24:445-456.
20. Koch CM, Andrews RM, Flicek P, Dillon SC, Karaoz U, Clelland GK, Wilcox S, Beare DM, Fowler JC, Couttet P, James KD, Lefebvre GC, Bruce AW, Dovey OM, Ellis PD, Dhami P, Langford CF, Weng Z, Birney E, Carter NP, Vetrie D, Dunham I. 2007. The landscape of histone modifications across 1% of the human genome in five human cell lines. Genome Res 17:691-707.
21. Lazarides E, Lindberg U. 1974. Actin is the naturally occurring inhibitor of deoxyribonuclease I. Proc Natl Acad Sci USA 71:4742-4746.
22. Li S, Hu GF. 2010. Angiogenin-mediated rRNA transcription in cancer and neurodegeneration. Int J Biochem Mol Biol 1:26-35.
23. Li S, Hu MG, Sun Y, Yoshioka N, Ibaragi S, Sheng J, Sun G, Kishimoto K, Hu GF. 2013a. Angiogenin mediates androgen-stimulated growth of prostate cancer cells and correlates with castration resistance. Mol Cancer Res July 12, 2013. Epub ahead of printPlease provide the volume number and page range.
24. Li S, Sheng J, Hu JK, Yu W, Kishikawa H, Hu MG, Shima K, Wu D, Xu Z, Xin W, Sims KB, Landers JE, Brown RH, Jr., Hu GF. 2013b. Ribonuclease 4 protects neuron degeneration by promoting angiogenesis, neurogenesis, and neuronal survival under stress. Angiogenesis 16:387-404.
25. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408.
26. Long EO, Dawid IB. 1980. Repeated genes in eukaryotes. Annu Rev Biochem 49:727-764.
27. McStay B, Grummt I. 2008. The epigenetics of rRNA genes: From molecular to chromosome biology. Annu Rev Cell Dev Biol 24:131-157.
28. Moroianu J, Riordan JF. 1994a. Identification of the nucleolar targeting signal of human angiogenin. Biochem Biophys Res Commun 203:1765-1772.
29. Moroianu J, Riordan JF. 1994b. Nuclear translocation of angiogenin in proliferating endothelial cells is essential to its angiogenic activity. Proc Natl Acad Sci USA 91:1677-1681.
30. Ogawa H, Ishiguro K, Gaubatz S, Livingston DM, Nakatani Y. 2002. A complex with chromatin modifiers that occupies E2F- and Myc-responsive genes in G0 cells. Science 296:1132-1136.
31. O'Sullivan AC, Sullivan GJ, McStay B. 2002. UBF binding in vivo is not restricted to regulatory sequences within the vertebrate ribosomal DNA repeat. Mol Cell Biol 22:657-668.
32. Panov KI, Friedrich JK, Zomerdijk JC. 2001. A step subsequent to preinitiation complex assembly at the ribosomal RNA gene promoter is rate limiting for human RNA polymerase I-dependent transcription. Mol Cell Biol 21:2641-2649.
33. Preuss S, Pikaard CS. 2007. rRNA gene silencing and nucleolar dominance: Insights into a chromosome-scale epigenetic on/off switch. Biochim Biophys Acta 1769:383-392.
34. Rea S, Eisenhaber F, O'Carroll D, Strahl BD, Sun ZW, Schmid M, Opravil S, Mechtler K, Ponting CP, Allis CD, Jenuwein T. 2000. Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature 406:593-599.
35. Rosenfeld JA, Wang Z, Schones DE, Zhao K, DeSalle R, Zhang MQ. 2009. Determination of enriched histone modifications in non-genic portions of the human genome. BMC Genomics 10:143.
36. Sanij E, Hannan RD. 2009. The role of UBF in regulating the structure and dynamics of transcriptionally active rDNA chromatin. Epigenetics 4:374-382.
37. Santoro R, Grummt I. 2001. Molecular mechanisms mediating methylation-dependent silencing of ribosomal gene transcription. Mol Cell 8:719-725.
38. Santoro R, Grummt I. 2005. Epigenetic mechanism of rRNA gene silencing: Temporal order of NoRC-mediated histone modification, chromatin remodeling, and DNA methylation. Mol Cell Biol 25:2539-2546.
39. Schubeler D, MacAlpine DM, Scalzo D, Wirbelauer C, Kooperberg C, van Leeuwen F, Gottschling DE, O'Neill LP, Turner BM, Delrow J, Bell SP, Groudine M. 2004. The histone modification pattern of active genes revealed through genome-wide chromatin analysis of a higher eukaryote. Genes Dev 18:1263-1271.
40. Schultz DC, Ayyanathan K, Negorev D, Maul GG, Rauscher FJ III. 2002. SETD B1: A novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins. Genes Dev 16:919-932.
41. Shapiro R, Harper JW, Fox EA, Jansen HW, Hein F, Uhlmann E. 1988. Expression of Met-(-1) angiogenin in Escherichia coli: Conversion to the authentic less than Glu-1 protein. Anal Biochem 175:450-461.
42. Strydom DJ, Kandror K. 1994. Identification of actin isoforms after in situ hydroxylamine cleavage on sequencer membranes: Serum actin is a cytoplasmic isoform. Biochem Biophys Res Commun 205:195-201.
43. Subramanian V, Crabtree B, Acharya KR. 2008. Human angiogenin is a neuroprotective factor and amyotrophic lateral sclerosis associated angiogenin variants affect neurite extension/pathfinding and survival of motor neurons. Hum Mol Genet 17:130-149.
44. Tachibana M, Sugimoto K, Nozaki M, Ueda J, Ohta T, Ohki M, Fukuda M, Takeda N, Niida H, Kato H, Shinkai Y. 2002. G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis. Genes Dev 16:1779-1791.
45. Tsuji T, Sun Y, Kishimoto K, Olson KA, Liu S, Hirukawa S, Hu GF. 2005. Angiogenin is translocated to the nucleus of HeLa cells and is involved in ribosomal RNA transcription and cell proliferation. Cancer Res 65:1352-1360.
46. van Es MA, Schelhaas HJ, van Vught PW, Ticozzi N, Andersen PM, Groen EJ, Schulte C, Blauw HM, Koppers M, Diekstra FP, Fumoto K, LeClerc AL, Keagle P, Bloem BR, Scheffer H, van Nuenen BF, van Blitterswijk M, van Rheenen W, Wills AM, Lowe PP, Hu GF, Yu W, Kishikawa H, Wu D, Folkerth RD, Mariani C, Goldwurm S, Pezzoli G, Van Damme P, Lemmens R, Dahlberg C, Birve A, Fernandez-Santiago R, Waibel S, Klein C, Weber M, van der Kooi AJ, de Visser M, Verbaan D, van Hilten JJ, Heutink P, Hennekam EA, Cuppen E, Berg D, Brown RH, Jr., Silani V, Gasser T, Ludolph AC, Robberecht W, Ophoff RA, Veldink JH, Pasterkamp RJ, de Bakker PI, Landers JE, van de Warrenburg BP, van den Berg LH. 2011. Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis. Ann Neurol 70:964-973.
47. Wu D, Yu W, Kishikawa H, Folkerth RD, Iafrate AJ, Shen Y, Xin W, Sims K, Hu GF. 2007. Angiogenin loss-of-function mutations in amyotrophic lateral sclerosis. Ann Neurol 62:609-617.
48. Xu ZP, Tsuji T, Riordan JF, Hu GF. 2002. The nuclear function of angiogenin in endothelial cells is related to rRNA production. Biochem Biophys Res Commun 294:287-292.
49. Xu ZP, Tsuji T, Riordan JF, Hu GF. 2003. Identification and characterization of an angiogenin-binding DNA sequence that stimulates luciferase reporter gene expression. Biochemistry 42:121-128.
50. Yoshioka N, Wang L, Kishimoto K, Tsuji T, Hu GF. 2006. A therapeutic target for prostate cancer based on angiogenin-stimulated angiogenesis and cancer cell proliferation. Proc Natl Acad Sci USA 103:14519-14524.
51. Yuan X, Feng W, Imhof A, Grummt I, Zhou Y. 2007. Activation of RNA polymerase I transcription by cockayne syndrome group B protein and histone methyltransferase G9a. Mol Cell 27:585-595.